We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

204 hedge funds and large institutions have $2.38B invested in Immunomedics Inc in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 85 increasing their positions, 51 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

570% more call options, than puts

Call options by funds: $75.3M | Put options by funds: $11.2M

67% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 51

12% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 26

0% more funds holding

Funds holding: 204 → 204 (0)

29% less capital invested

Capital invested by funds: $3.37B → $2.38B (-$992M)

36% less funds holding in top 10

Funds holding in top 10: 11 → 7 (-4)

Holders
204
Holders Change
–
Holders Change %
0%
% of All Funds
4.43%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.15%
New
29
Increased
85
Reduced
51
Closed
26
Calls
$75.3M
Puts
$11.2M
Net Calls
+$64M
Net Calls Change
+$13.6M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$49.4M
2
Citadel Advisors
Citadel Advisors
Florida
+$47.8M
3
BC
Boxer Capital
California
+$37.1M
4
BlackRock
BlackRock
New York
+$18.7M
5
DM
Deerfield Management
New York
+$17.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$153M
2
O
OrbiMed
New York
-$51.9M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$44.5M
4
Victory Capital Management
Victory Capital Management
Texas
-$40.9M
5
SCM
Scopia Capital Management
New York
-$37.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
176
Steward Partners Investment Advisory
New York
$49K +$54.2K +3,600 New
ASN
177
Advisory Services Network
Georgia
$43K – – –
GRP
178
Global Retirement Partners
California
$40K +$15K +1,000 +52%
SSB
179
Sandy Spring Bank
Maryland
$38K – – –
VFA
180
Valeo Financial Advisors
Indiana
$33K – – –
CAW
181
Cornerstone Advisors (Washington)
Washington
$29K – – –
VRM
182
Vectors Research Management
New York
$28K – – –
LTFS
183
Ladenburg Thalmann Financial Services
Florida
$26K +$286 +19 +1%
FHA
184
First Horizon Advisors
Tennessee
$18K – – –
FHA
185
Flagship Harbor Advisors
Massachusetts
$17K -$2.33K -155 -11%
Daiwa Securities Group
186
Daiwa Securities Group
Japan
$17K – – –
TC
187
Truvestments Capital
Florida
$14K – – –
IWA
188
IBEX Wealth Advisors
New Jersey
$13K +$15K +1,000 New
CAPTRUST Financial Advisors
189
CAPTRUST Financial Advisors
North Carolina
$12K – – –
AC
190
Avestar Capital
New York
$9K – – –
BFC
191
Bedel Financial Consulting
Indiana
$9K – – –
Nisa Investment Advisors
192
Nisa Investment Advisors
Missouri
$9K – – –
NFG
193
Next Financial Group
Texas
$9K +$10K +667 +4,447%
EWA
194
Evolution Wealth Advisors
Florida
$8K +$9.19K +611 New
AIC
195
Archer Investment Corporation
Indiana
$7K – – –
AOWM
196
Alpha Omega Wealth Management
Virginia
$5K – – –
PGAM
197
Princeton Global Asset Management
New Jersey
$3K +$3.6K +239 New
CFGS
198
Concourse Financial Group Securities
Alabama
$2K -$918 -61 -35%
TRCT
199
Tower Research Capital (TRC)
New York
$2K +$2.17K +144 New
ED
200
Exane Derivatives
France
$1.91K -$88.2K -5,861 -98%
6 7
8
9 10

IMMU Hedge Fund Activity: Q2 2019 in Review

204 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2019, worth a combined $2.38B — down 29% from $3.37B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IMMU positions and 26 closed out — a net gain of 3 holders — while 85 added to existing stakes and 51 trimmed.

The largest buyer was Avoro Capital Advisors, adding an estimated $49.4M. The largest seller was Fidelity Investments, cutting an estimated $153M.

  • 204 institutional investors held Immunomedics Inc (IMMU) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $2.38B of Immunomedics Inc stock for Q2 2019, down 29% quarter-over-quarter.
  • 29 funds opened new Immunomedics Inc positions in Q2 2019 and 26 closed out, a net change of +3 holders.
  • The largest Immunomedics Inc buyer in Q2 2019 was Avoro Capital Advisors, an estimated $49.4M added.
  • The largest Immunomedics Inc seller in Q2 2019 was Fidelity Investments, an estimated $153M sold.

Based on aggregated 13F filings for Q2 2019.